Back

Antiarrhythmic Medication for Atrial Fibrillation (AIM-AF) study: A physician survey of sotalol use and patient monitoring in the EU and USA

23 April 2021 (14:00 - 21:00)
Organised by:
Congress Presentation Part of: ePoster session Treatment EHRA Premium Access EHRA 2021

About the speaker

Photo
Professor James A Reiffel

Columbia University Medical Centre, New York (United States of America)

286 More presentations in this session

Presentation thumbnail
Non-valvular atrial fibrillation recurrence after sinus rhythm restoring at different follow-up periods: phenotype-genotype high-risk groups, considering rs10465885 polymorphism in connexin-40 gene
Doctor T. Mikhalieva (Kyiv, UA)
Abstract Slides
Presentation thumbnail
Atrial fibrillation substrate mapping with decrement evoked potential mapping.
Doctor O. Salvador (Parla, ES)
Abstract Slides
Presentation thumbnail
Atrial tissue characterization by cardiac magnetic resonance and high-density mapping in patients with atrial fibrillation
Miss R. Adelino Recasens (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Proarrhythmic atrial structural and molecular remodeling with advancing age. Implications for post-coronary artery bypass grafting atrial fibrillation occurrence.
Doctor R. SERBAN (Targu Mures, RO)
Abstract Slides
Presentation thumbnail
Find me if you can: lessons learned using the novel cartofinder algorithm in a routine workflow for catheter ablation of atrial fibrillation
Doctor C. Sohns (Bad Oeynhausen, DE)
Abstract Slides

Access the full session

Session thumbnail
ePoster session

The Event

Event poster

EHRA 2021

23 April 2021 14:00 CET
You may be interested in
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
thumbnail
Congress Session
EHRA Myths - Device-detected atrial fibrillation
thumbnail
Congress Presentation
AF-CARE: “R” Rate and rhythm control

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources